Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 11 (Search time: 0.423 seconds).

  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients (Journal article)

  Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study (Journal article)

  Targeting vascular risk in patients with metabolic syndrome but without diabetes (Journal article)

  Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels (Journal article)

  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? (Journal article)

  Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study (Journal article)

  Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study (Journal article)

  Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia (Journal article)

  Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study (Journal article)

  Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort (Journal article)